GlassScriptPhysician profile
Heather N Doherty
NPI 1255319802
$617.22
in general payments reported to CMS, 2019-2025
8 companies · $292 in 2025
The $292 reported for 2025 was more than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2022: $18.81 · 2023: $78.62 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $239.64 | 2019-2025 | |
| Blueprint Medicines Corporation | $124.99 | 2025 | Ayvakit |
| Teva Pharmaceuticals USA, INC. | $112.08 | 2019 | |
| Glaxosmithkline, LLC. | $64.21 | 2023 | Shingrix, Arexvy, Bexsero |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.38 | 2025 | Jardiance |
| Baxter Healthcare | $19.70 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Pharmacyclics LLC, An Abbvie Company | $18.81 | 2022 | |
| Idorsia Pharmaceuticals US INC | $14.41 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Doherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.